https://pharminent.com/fda-grants-jemperli-accelerated-approval-in-locally-advanced-rectal-cancer/ 2026-10-20T12:16:42Z Pharminent en AstraZeneca and Oracle launch AI platform for clinical trials 2026-10-20T11:45:55Z Blog https://pharminent.com/week-in-review/week-in-review-intelligence-brief-october-17-2026/ 2026-10-19T16:28:34Z Pharminent en Week in Review • INTELLIGENCE BRIEF • October 17, 2026 2026-10-19T16:28:34Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-october-16-2026/ 2026-10-19T16:28:20Z Pharminent en Oncology Intelligence Digest • October 16, 2026 2026-10-19T16:28:20Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-october-19-2026/ 2026-10-19T14:53:53Z Pharminent en Strategic News Watch • October 19, 2026 2026-10-19T14:53:53Z Blog https://pharminent.com/fda-approves-viatris-ryzumvi-for-adult-presbyopia/ 2026-10-19T11:45:45Z Pharminent en FDA approves Viatris' Ryzumvi for adult presbyopia 2026-10-19T11:45:45Z Blog